APAC HIV Diagnostic Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5011

  • Format: PPT, PDF

APAC HIV Diagnostic Market Analysis: Segmented by Product, Type, End user, Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5011 Categories: ,

Report Description of the APAC HIV Diagnostic Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC HIV Diagnostic Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC HIV Diagnostic Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC HIV Diagnostic Market Analysis Executive Summaryc

HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV includes testing services in health-care facilities, free-standing sites, and a wide range of community-based approaches along with HIV self-testing. Developments such as home testing represent new and major opportunities for addressing HIV among men who have sex with men (MSM). According to the UNAIDS, the Joint United Nations Program on HIV and AIDS, 2018 data, Asia Pacific recorded around 5.2 million people living with HIV in 2017.

Market Size and Key Findings

The APAC HIV Diagnostic Market Analysis size stood at around USD 0.75% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 10.40% during the forecast period.

The size of the Asia Pacific HIV Diagnostics Market is valued at USD 750.72 million in 2020. It is estimated to be growing at a growth rate of 10.40% to reach 1231.19 million by 2028.

Market Dynamics

Market Growth Drivers Analysis

The rise in the spread rate of infectious diseases, the increase in population growth, increased awareness on early screening for diseases and its treatment will increase the market growth, increased set-ups of diagnostic centers, medical centers, clinics, hospitals also increase the market growth. Fully developed infrastructure and healthcare, medical facilities, medical health plans, and schemes, reimbursement policies raise demand for HIV diagnostic market. Government initiatives towards creating awareness in public about safety measures, controlling the rapid spread of infections, maintaining a healthy lifestyle, early screening of diseases, and its treatment increase market size. Rapid growth in clinical examinations and diagnostic tests, easy availability of health screening facilities, affordable range health check-up plans are also increasing market size. An increase in the number of products offers also gears up to market size. Government and non-government funds, public investors are growing demand for this market.

Market Restraints

There are few market restraints held back market growth. Factors such as limited availability of test tools and kits in the market are currently seen, which negatively impacts the market. A few tests and kits are still under clinical investigation. Delayed or slow processing of such activities will hamper the market growth. Noon affordable range of drugs for treatment, hospitality charges are reported as significant patients’ concerns. However, the government provides beneficial schemes under the healthcare economy, few backward people are still unable to receive these benefits due to lack of awareness on early screening and lifestyle. The low literacy rate is more in this region, and hence due to this, there is more unawareness of disease and diagnosis. This healthy lifestyle is showing an impact on the HIV diagnostics market. The testing procedures and handling needs for professional and skilled workers. Lack of experienced staff will turn out as a negative mark for this market. The high costs of drugs and its side effects are more often a concern for patients, so patients are not readily adaptable to these systems. Testing equipment and devices need to be quality checked and monitored daily. Hence the delay in this process will mask market growth. Fewer times, the test’s accuracy is not possible due to testing kit errors or reagent errors. Also, the utilization of reagents and tools are more for carrying out these products.

COVID-19 impact on “APAC HIV Diagnostic Market Analysis” 

The HIV drugs market has been negatively impacted by the COVID-19 pandemic. Furthermore, as per the industry experts, long-term effects of the COVID-19 outbreak are expected to be witnessed over the coming years. The outbreak has led to a situation of financial crisis in many countries. In addition, failure of suppliers to deliver ARVs (antiretroviral drug) on time, shutdown of land & air transport services, and limited access to health services within countries as a result of the pandemic are anticipated to negatively impact the HIV drugs market in the future.

Competitive Landscape

Key Players

The competitive landscape for the global HIV drugs market has the presence of key market players, such as Viiv Healthcare, Gilead Sciences, Janssen Pharmaceuticals, Inc., and Merck Sharp & Dohme Corp. These companies comprise a major proportion of the market. These key players dominate the HIV market owing to their strong sales of antiretroviral drugs with new product launches and strategic collaborations for the enlargement of their product portfolios. For instance, in March 2021, Gilead Sciences Inc. and Merck Sharp & Dohme entered into an agreement for the co-development and co-commercialization of long-acting treatment with the combinations of Islatravir and Lenacapavir for HIV patients.

Competitive Landscape

Key Players

The competitive landscape for the global HIV drugs market has the presence of key market players, such as Viiv Healthcare, Gilead Sciences, Janssen Pharmaceuticals, Inc., and Merck Sharp & Dohme Corp. These companies comprise a major proportion of the market. These key players dominate the HIV market owing to their strong sales of antiretroviral drugs with new product launches and strategic collaborations for the enlargement of their product portfolios. For instance, in March 2021, Gilead Sciences Inc. and Merck Sharp & Dohme entered into an agreement for the co-development and co-commercialization of long-acting treatment with the combinations of Islatravir and Lenacapavir for HIV patients.

Products in Pipeline

The rising emphasis on R&D activities in the field of HIV drugs is expected to result in the rising drug innovations worldwide. Several reputed companies, such as Boehringer Ingelheim International GmbH, ViiV Healthcare, and Gilead Sciences are engaging in investment initiatives to compete in the market. Some of the others are participating in new product launches and collaborations. In September 2019, for instance, Merck Sharp & Dohme Corp. won the U.S. FDA approval for DELSTRIGO and PIFELTRO combination drugs. These will be used for the treatment of people living with HIV-1. However, many people suffering from this disease across the globe do not have access to timely treatment. It may obstruct the market growth in the near future.

Notable Recent Deals

  • In 2014, UNAIDS, the Joint United Nations Program on HIV and AIDS, is engaged in global efforts to end AIDS as a public health threat by 2030 and is a part of the UN Sustainable Development Goal. According to UNAIDS targets, by 2020, 90% of all people living with HIV will know HIV status and 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. Furthermore, around US$ 3.7 billion was available in 2017 for the AIDS response in Asia Pacific, according to UNAIDS.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Governments of various countries in Asia Pacific are taking initiatives to create awareness regarding HIV among people due to high prevalence of HIV/AIDS in the region. This in turn is increasing adoption of HIV diagnostic instruments and test kits. Low literacy rate coupled with unawareness regarding transmission mode on HIV, changing lifestyle, and unsafe sex are some of the factors leading to increasing number of HIV cases. In order to lower the disease incidence and increase life expectancy of infected patients, governments of various countries along with NGOs are focusing on improving HIV diagnostics and making them easily accessible to the general population.

1. Report Description of the APAC HIV Diagnostic Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC HIV Diagnostic Market Analysis Executive Summary
2.1 APAC HIV Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC HIV Diagnostic Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Developed Infrastructure
3.1.2 Government Initiatives
3.1.3 Increased awareness
3.2 Market Restraints Analysis
3.2.1 Limited availability of test tools
3.2.2 Delayed or slow processing
3.2.3 Non-affordable range of drugs
3.3 Covid-19 Market Impact Analysis
4. APAC HIV Diagnostic Market Segmentation
4.1 By Product:
4.1.1 Consumables
4.1.2 Instruments
4.1.3 Software & Services
4.2 By Type
4.2.1 Antibody Tests
4.2.2 Viral Identification Tests
4.2.3 CD4 Testing
4.2.4 Viral Load Testing
4.2.5 Early Infant Diagnostics
4.3 By End-user:
4.3.1 Diagnostic Laboratories
4.3.2 Hospitals
4.3.3 Blood Banks
4.3.4 Home Care Settings
4.3.5 Other End users
4.4 By Country:
4.4.1 China
4.4.2 India
4.4.3 Japan
4.4.4 South Korea
4.4.5 Australia
4.4.6 New Zealand
4.4.7 Thailand
4.4.8 Malaysia
4.4.9 Vietnam
4.4.10 Philippines
4.4.11 Indonesia
4.4.12 Singapore
4.4.13 Rest of APAC
5. APAC HIV Diagnostic Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in HIV Market
6.4 Notable recent deals in HIV Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Abbott Healthcare Company overview
Product & Services, Strategies & Financials
7.2 Roche AG overview
Product & Services, Strategies & Financials
7.3 Abbvie Inc. Company overview
Product & Services, Strategies & Financials
7.4 Gilead Sciences Company overview
Product & Services, Strategies & Financials
7.5 Merck & Company Inc. overview
Product & Services, Strategies & Financials
7.6 BD Biosciences Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of HIV market
9.2 Future Opportunities
10. Strategic Recommendations

APAC HIV Diagnostic Market Analysis Segmentation

By Product

  • Consumables
  • Instruments
  • Software & Services

By Type:

  • Antibody Tests
  • Viral Identification Tests
  • CD4 Testing
  • Viral Load Testing
  • Early Infant Diagnostics

By End-User:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End users

By Country:

The Asia Pacific will see the highest market growth in coming years than earlier due to its medical and research advancements, technological developments, population growth, rise in spread rate of infectious diseases, rise in early screening for diseases and treatment, and increased medical plans and reimbursement policies. China and Japan are highly populated countries, and hence the screening tests carried out are more comparatively. China alone commands for a more spread rate of infectious diseases. In recent years, India fuelled its research activities in biotechnology, medicine, and pharmaceuticals to bring up new vaccines and a combination of drugs. However, low literacy rates and unawareness in people for healthy lifestyle activities and early screening for diseases in India will hamper the market growth.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements